nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—DRD2—Parkinson's disease	0.461	0.564	CbGaD
Droperidol—HTR2A—Parkinson's disease	0.356	0.436	CbGaD
Droperidol—HTR2A—enteric nervous system—Parkinson's disease	0.00986	0.109	CbGeAlD
Droperidol—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00748	0.0826	CbGeAlD
Droperidol—HTR2A—locus ceruleus—Parkinson's disease	0.00651	0.0719	CbGeAlD
Droperidol—HTR2A—cerebellar cortex—Parkinson's disease	0.00531	0.0586	CbGeAlD
Droperidol—HTR2A—sympathetic nervous system—Parkinson's disease	0.00515	0.0569	CbGeAlD
Droperidol—DRD2—telencephalic ventricle—Parkinson's disease	0.00468	0.0517	CbGeAlD
Droperidol—HTR2A—pons—Parkinson's disease	0.00375	0.0415	CbGeAlD
Droperidol—HTR2A—autonomic nervous system—Parkinson's disease	0.00346	0.0382	CbGeAlD
Droperidol—HTR2A—telencephalic ventricle—Parkinson's disease	0.00309	0.0341	CbGeAlD
Droperidol—DRD2—nerve—Parkinson's disease	0.00295	0.0326	CbGeAlD
Droperidol—HTR2A—peripheral nervous system—Parkinson's disease	0.0025	0.0276	CbGeAlD
Droperidol—ADRA1A—hindbrain—Parkinson's disease	0.00225	0.0249	CbGeAlD
Droperidol—DRD2—hindbrain—Parkinson's disease	0.00221	0.0244	CbGeAlD
Droperidol—HTR2A—nerve—Parkinson's disease	0.00195	0.0215	CbGeAlD
Droperidol—HTR2A—hindbrain—Parkinson's disease	0.00146	0.0161	CbGeAlD
Droperidol—ADRA1A—brainstem—Parkinson's disease	0.00129	0.0143	CbGeAlD
Droperidol—DRD2—brainstem—Parkinson's disease	0.00127	0.014	CbGeAlD
Droperidol—ADRA1A—forebrain—Parkinson's disease	0.00125	0.0138	CbGeAlD
Droperidol—DRD2—forebrain—Parkinson's disease	0.00122	0.0135	CbGeAlD
Droperidol—KCNH2—forebrain—Parkinson's disease	0.0012	0.0133	CbGeAlD
Droperidol—ADRA1A—cardiovascular system—Parkinson's disease	0.00105	0.0117	CbGeAlD
Droperidol—KCNH2—cardiovascular system—Parkinson's disease	0.00102	0.0113	CbGeAlD
Droperidol—Haloperidol—GRIN2B—Parkinson's disease	0.000966	0.114	CrCbGaD
Droperidol—HTR2A—embryo—Parkinson's disease	0.000912	0.0101	CbGeAlD
Droperidol—KCNH2—medulla oblongata—Parkinson's disease	0.00087	0.00961	CbGeAlD
Droperidol—HTR2A—brainstem—Parkinson's disease	0.000836	0.00923	CbGeAlD
Droperidol—DRD2—midbrain—Parkinson's disease	0.000807	0.00892	CbGeAlD
Droperidol—HTR2A—forebrain—Parkinson's disease	0.000806	0.00891	CbGeAlD
Droperidol—KCNH2—midbrain—Parkinson's disease	0.000795	0.00879	CbGeAlD
Droperidol—KCNH2—spinal cord—Parkinson's disease	0.000776	0.00857	CbGeAlD
Droperidol—ADRA1A—head—Parkinson's disease	0.000714	0.00789	CbGeAlD
Droperidol—DRD2—head—Parkinson's disease	0.0007	0.00773	CbGeAlD
Droperidol—KCNH2—head—Parkinson's disease	0.00069	0.00762	CbGeAlD
Droperidol—HTR2A—cardiovascular system—Parkinson's disease	0.000682	0.00753	CbGeAlD
Droperidol—ADRA1A—nervous system—Parkinson's disease	0.000677	0.00748	CbGeAlD
Droperidol—DRD2—nervous system—Parkinson's disease	0.000664	0.00733	CbGeAlD
Droperidol—KCNH2—nervous system—Parkinson's disease	0.000654	0.00722	CbGeAlD
Droperidol—ADRA1A—central nervous system—Parkinson's disease	0.000652	0.0072	CbGeAlD
Droperidol—Domperidone—DRD3—Parkinson's disease	0.000643	0.0757	CrCbGaD
Droperidol—DRD2—central nervous system—Parkinson's disease	0.000639	0.00706	CbGeAlD
Droperidol—ADRA1A—cerebellum—Parkinson's disease	0.000637	0.00704	CbGeAlD
Droperidol—KCNH2—central nervous system—Parkinson's disease	0.00063	0.00695	CbGeAlD
Droperidol—DRD2—cerebellum—Parkinson's disease	0.000625	0.0069	CbGeAlD
Droperidol—KCNH2—cerebellum—Parkinson's disease	0.000615	0.0068	CbGeAlD
Droperidol—Fluspirilene—HTR1A—Parkinson's disease	0.000586	0.069	CrCbGaD
Droperidol—HTR2A—medulla oblongata—Parkinson's disease	0.000583	0.00644	CbGeAlD
Droperidol—Pimozide—DRD3—Parkinson's disease	0.000537	0.0633	CrCbGaD
Droperidol—HTR2A—midbrain—Parkinson's disease	0.000532	0.00588	CbGeAlD
Droperidol—HTR2A—spinal cord—Parkinson's disease	0.00052	0.00574	CbGeAlD
Droperidol—ADRA1A—brain—Parkinson's disease	0.000518	0.00572	CbGeAlD
Droperidol—DRD2—brain—Parkinson's disease	0.000507	0.0056	CbGeAlD
Droperidol—KCNH2—brain—Parkinson's disease	0.0005	0.00552	CbGeAlD
Droperidol—Fluspirilene—DRD2—Parkinson's disease	0.000498	0.0586	CrCbGaD
Droperidol—Haloperidol—DRD3—Parkinson's disease	0.000491	0.0578	CrCbGaD
Droperidol—Haloperidol—DRD1—Parkinson's disease	0.000482	0.0567	CrCbGaD
Droperidol—HTR2A—head—Parkinson's disease	0.000462	0.0051	CbGeAlD
Droperidol—Domperidone—DRD2—Parkinson's disease	0.000445	0.0524	CrCbGaD
Droperidol—Pimozide—HTR1A—Parkinson's disease	0.000438	0.0516	CrCbGaD
Droperidol—HTR2A—nervous system—Parkinson's disease	0.000438	0.00484	CbGeAlD
Droperidol—HTR2A—central nervous system—Parkinson's disease	0.000421	0.00466	CbGeAlD
Droperidol—HTR2A—cerebellum—Parkinson's disease	0.000412	0.00455	CbGeAlD
Droperidol—Fluspirilene—HTR2A—Parkinson's disease	0.000384	0.0453	CrCbGaD
Droperidol—Pimozide—DRD2—Parkinson's disease	0.000372	0.0438	CrCbGaD
Droperidol—Pimozide—CYP2E1—Parkinson's disease	0.000358	0.0421	CrCbGaD
Droperidol—Haloperidol—DRD2—Parkinson's disease	0.00034	0.04	CrCbGaD
Droperidol—HTR2A—brain—Parkinson's disease	0.000335	0.0037	CbGeAlD
Droperidol—Domperidone—CYP2D6—Parkinson's disease	0.000315	0.037	CrCbGaD
Droperidol—Pimozide—HTR2A—Parkinson's disease	0.000287	0.0338	CrCbGaD
Droperidol—Pimozide—CYP2D6—Parkinson's disease	0.000263	0.0309	CrCbGaD
Droperidol—Haloperidol—HTR2A—Parkinson's disease	0.000262	0.0309	CrCbGaD
Droperidol—Haloperidol—CYP2D6—Parkinson's disease	0.00024	0.0282	CrCbGaD
Droperidol—Domperidone—ABCB1—Parkinson's disease	0.000225	0.0265	CrCbGaD
Droperidol—Pimozide—ABCB1—Parkinson's disease	0.000188	0.0221	CrCbGaD
Droperidol—Haloperidol—ABCB1—Parkinson's disease	0.000171	0.0202	CrCbGaD
Droperidol—HTR2A—Signaling by GPCR—GPR37—Parkinson's disease	0.000109	0.0013	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—DGKQ—Parkinson's disease	0.000109	0.0013	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000109	0.0013	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000109	0.0013	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000107	0.00128	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—DGKQ—Parkinson's disease	0.000107	0.00127	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GPR37—Parkinson's disease	0.000107	0.00127	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000107	0.00127	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000105	0.00126	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000103	0.00123	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.000103	0.00123	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000101	0.00121	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.000101	0.00121	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.0001	0.0012	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PPP1R1B—Parkinson's disease	9.96e-05	0.00119	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—ADORA2A—Parkinson's disease	9.89e-05	0.00118	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—HTR2A—Parkinson's disease	9.87e-05	0.00118	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PPP1R1B—Parkinson's disease	9.75e-05	0.00117	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	9.69e-05	0.00116	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—ADORA2A—Parkinson's disease	9.68e-05	0.00116	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	9.53e-05	0.00114	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	9.53e-05	0.00114	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	9.33e-05	0.00112	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	9.33e-05	0.00112	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	9.25e-05	0.00111	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—GRK5—Parkinson's disease	9.24e-05	0.0011	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—GRK5—Parkinson's disease	9.09e-05	0.00109	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—GRK5—Parkinson's disease	8.9e-05	0.00106	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	8.83e-05	0.00106	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—HTR1A—Parkinson's disease	8.72e-05	0.00104	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—TAC1—Parkinson's disease	8.59e-05	0.00103	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—HTR1A—Parkinson's disease	8.58e-05	0.00103	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—TAC1—Parkinson's disease	8.45e-05	0.00101	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—DRD1—Parkinson's disease	8.42e-05	0.00101	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—HTR1A—Parkinson's disease	8.4e-05	0.001	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—GRK5—Parkinson's disease	8.39e-05	0.001	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—DRD1—Parkinson's disease	8.29e-05	0.000991	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—GRM4—Parkinson's disease	8.29e-05	0.00099	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—TAC1—Parkinson's disease	8.27e-05	0.000989	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—GRK5—Parkinson's disease	8.25e-05	0.000987	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—DRD3—Parkinson's disease	8.16e-05	0.000975	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—GRM4—Parkinson's disease	8.15e-05	0.000975	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—DRD1—Parkinson's disease	8.11e-05	0.00097	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GRK5—Parkinson's disease	8.08e-05	0.000966	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—DRD3—Parkinson's disease	8.02e-05	0.000959	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—GRM4—Parkinson's disease	7.98e-05	0.000954	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	7.92e-05	0.000947	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VPS35—Parkinson's disease	7.89e-05	0.000943	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—DRD3—Parkinson's disease	7.86e-05	0.000939	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PENK—Parkinson's disease	7.85e-05	0.000939	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VPS35—Parkinson's disease	7.76e-05	0.000928	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	7.75e-05	0.000927	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PENK—Parkinson's disease	7.73e-05	0.000924	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	7.63e-05	0.000912	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	7.63e-05	0.000912	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VPS35—Parkinson's disease	7.6e-05	0.000909	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PENK—Parkinson's disease	7.57e-05	0.000905	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—GRM4—Parkinson's disease	7.52e-05	0.000899	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	7.47e-05	0.000893	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	7.46e-05	0.000892	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—GRM4—Parkinson's disease	7.4e-05	0.000885	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—HTR7—Parkinson's disease	7.38e-05	0.000882	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—HTR7—Parkinson's disease	7.26e-05	0.000868	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—DRD2—Parkinson's disease	7.26e-05	0.000868	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GRM4—Parkinson's disease	7.25e-05	0.000867	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PDYN—Parkinson's disease	7.18e-05	0.000859	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PENK—Parkinson's disease	7.13e-05	0.000853	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—HTR7—Parkinson's disease	7.11e-05	0.000849	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—DRD2—Parkinson's disease	7.11e-05	0.000849	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PDYN—Parkinson's disease	7.07e-05	0.000845	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PENK—Parkinson's disease	7.02e-05	0.000839	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PDYN—Parkinson's disease	6.92e-05	0.000827	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	6.91e-05	0.000825	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	6.89e-05	0.000824	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PENK—Parkinson's disease	6.87e-05	0.000822	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	6.78e-05	0.000811	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	6.68e-05	0.000798	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—GRM5—Parkinson's disease	6.57e-05	0.000786	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GPR37—Parkinson's disease	6.54e-05	0.000782	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	6.54e-05	0.000782	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	6.54e-05	0.000781	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	6.52e-05	0.00078	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—GRM5—Parkinson's disease	6.43e-05	0.000769	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—DGKQ—Parkinson's disease	6.43e-05	0.000769	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GPR37—Parkinson's disease	6.43e-05	0.000769	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PDYN—Parkinson's disease	6.42e-05	0.000767	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GPR37—Parkinson's disease	6.3e-05	0.000753	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DGKQ—Parkinson's disease	6.3e-05	0.000753	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PDYN—Parkinson's disease	6.29e-05	0.000751	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	6.06e-05	0.000725	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	5.98e-05	0.000715	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—GRM5—Parkinson's disease	5.97e-05	0.000713	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	5.91e-05	0.000706	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PPP1R1B—Parkinson's disease	5.88e-05	0.000703	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GRM5—Parkinson's disease	5.84e-05	0.000699	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—EDN1—Parkinson's disease	5.81e-05	0.000695	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PPP1R1B—Parkinson's disease	5.76e-05	0.000689	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—EDN1—Parkinson's disease	5.69e-05	0.00068	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.68e-05	0.000679	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.59e-05	0.000668	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.47e-05	0.000654	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	5.25e-05	0.000628	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RIT2—Parkinson's disease	5.23e-05	0.000625	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	5.17e-05	0.000618	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	5.16e-05	0.000616	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RIT2—Parkinson's disease	5.14e-05	0.000615	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADORA2A—Parkinson's disease	5.07e-05	0.000607	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RIT2—Parkinson's disease	5.04e-05	0.000602	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	5.01e-05	0.000599	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—HTR2A—Parkinson's disease	4.98e-05	0.000595	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADORA2A—Parkinson's disease	4.97e-05	0.000594	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GRK5—Parkinson's disease	4.96e-05	0.000592	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	4.93e-05	0.000589	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GRK5—Parkinson's disease	4.88e-05	0.000583	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	4.85e-05	0.00058	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—HTR1A—Parkinson's disease	4.85e-05	0.00058	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—TAC1—Parkinson's disease	4.77e-05	0.000571	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GRK5—Parkinson's disease	4.77e-05	0.000571	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	4.76e-05	0.000569	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HTR1A—Parkinson's disease	4.75e-05	0.000568	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—DRD1—Parkinson's disease	4.68e-05	0.00056	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—TAC1—Parkinson's disease	4.68e-05	0.000559	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	4.61e-05	0.000551	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—DRD1—Parkinson's disease	4.58e-05	0.000548	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—DRD3—Parkinson's disease	4.53e-05	0.000542	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	4.47e-05	0.000535	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GRM4—Parkinson's disease	4.44e-05	0.000531	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	4.44e-05	0.000531	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	4.41e-05	0.000527	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HTR1A—Parkinson's disease	4.4e-05	0.000526	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GRM4—Parkinson's disease	4.37e-05	0.000523	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—TAC1—Parkinson's disease	4.34e-05	0.000518	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	4.32e-05	0.000517	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	4.31e-05	0.000515	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.3e-05	0.000514	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	4.28e-05	0.000512	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—DRD1—Parkinson's disease	4.25e-05	0.000508	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	4.25e-05	0.000508	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.23e-05	0.000506	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PENK—Parkinson's disease	4.21e-05	0.000504	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAG—Parkinson's disease	4.21e-05	0.000504	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	4.19e-05	0.0005	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	4.17e-05	0.000498	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	4.16e-05	0.000498	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.15e-05	0.000496	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAG—Parkinson's disease	4.15e-05	0.000496	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PENK—Parkinson's disease	4.15e-05	0.000496	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—DRD3—Parkinson's disease	4.12e-05	0.000492	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—DRD2—Parkinson's disease	4.1e-05	0.00049	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—HTR7—Parkinson's disease	4.1e-05	0.00049	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	4.06e-05	0.000485	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	4.06e-05	0.000485	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.04e-05	0.000483	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	4.03e-05	0.000482	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	4.02e-05	0.00048	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	4.02e-05	0.00048	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	3.91e-05	0.000467	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PDYN—Parkinson's disease	3.85e-05	0.000461	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	3.85e-05	0.00046	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	3.79e-05	0.000453	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	3.79e-05	0.000452	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	3.77e-05	0.00045	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	3.72e-05	0.000445	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	3.72e-05	0.000445	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	3.71e-05	0.000444	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	3.65e-05	0.000436	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	3.65e-05	0.000436	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GFAP—Parkinson's disease	3.62e-05	0.000433	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GRM5—Parkinson's disease	3.58e-05	0.000428	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	3.57e-05	0.000426	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	3.53e-05	0.000421	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	3.49e-05	0.000417	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	3.45e-05	0.000413	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	3.36e-05	0.000401	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	3.34e-05	0.000399	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	3.28e-05	0.000393	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	3.22e-05	0.000384	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGF20—Parkinson's disease	3.14e-05	0.000376	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.13e-05	0.000374	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	3.09e-05	0.00037	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.06e-05	0.000366	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	3.05e-05	0.000364	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	3.03e-05	0.000362	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	3.03e-05	0.000362	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	3e-05	0.000358	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	2.98e-05	0.000356	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	2.94e-05	0.000351	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	2.92e-05	0.000349	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	2.92e-05	0.000349	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	2.81e-05	0.000336	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INSR—Parkinson's disease	2.81e-05	0.000336	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INSR—Parkinson's disease	2.77e-05	0.000331	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	2.71e-05	0.000324	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGB—Parkinson's disease	2.66e-05	0.000318	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	2.65e-05	0.000317	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	2.64e-05	0.000316	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGB—Parkinson's disease	2.61e-05	0.000313	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TAC1—Parkinson's disease	2.6e-05	0.000311	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	2.6e-05	0.000311	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	2.56e-05	0.000306	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	2.56e-05	0.000306	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	2.55e-05	0.000305	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—DRD1—Parkinson's disease	2.55e-05	0.000305	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	2.55e-05	0.000304	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	2.51e-05	0.0003	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	2.51e-05	0.0003	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—DRD3—Parkinson's disease	2.47e-05	0.000296	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	2.46e-05	0.000294	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	2.43e-05	0.000291	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	2.38e-05	0.000285	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	2.31e-05	0.000276	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	2.27e-05	0.000272	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR7—Parkinson's disease	2.24e-05	0.000267	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	2.22e-05	0.000266	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	2.2e-05	0.000263	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	2.2e-05	0.000263	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	2.15e-05	0.000258	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	2.15e-05	0.000258	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.87e-05	0.000224	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	1.84e-05	0.00022	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.81e-05	0.000217	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	1.81e-05	0.000216	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.79e-05	0.000214	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	1.78e-05	0.000213	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	1.76e-05	0.000211	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	1.75e-05	0.000209	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	1.72e-05	0.000206	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NGF—Parkinson's disease	1.65e-05	0.000197	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NGF—Parkinson's disease	1.62e-05	0.000193	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	1.58e-05	0.000189	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	1.57e-05	0.000187	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	1.51e-05	0.00018	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOE—Parkinson's disease	1.46e-05	0.000174	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOE—Parkinson's disease	1.43e-05	0.000171	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	1.4e-05	0.000168	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INS—Parkinson's disease	1.24e-05	0.000149	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INS—Parkinson's disease	1.22e-05	0.000146	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INS—Parkinson's disease	1.2e-05	0.000143	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CASP3—Parkinson's disease	9.26e-06	0.000111	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—Parkinson's disease	9.2e-06	0.00011	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	9.11e-06	0.000109	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	9.05e-06	0.000108	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	8.92e-06	0.000107	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	8.86e-06	0.000106	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	8.51e-06	0.000102	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	8.37e-06	0.0001	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	8.2e-06	9.8e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—Parkinson's disease	5.43e-06	6.5e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—Parkinson's disease	5.35e-06	6.39e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	5.24e-06	6.26e-05	CbGpPWpGaD
